Experimental Ebola Vaccine Shipped to Liberia by GlaxoSmithKline!


According to Guardian, the Chief Executive Officer (CEO) of GlaxoSmithKline (GSK), Sir Andrew Witty, says he’s hopeful for the potential Ebola vaccine that is now on its way to West Africa. The goal of GSK is to enrol 30,000 people in the first large-scale trials of the vaccine, with Medical/Healthcare workers and others